News
Iovance Biotherapeutics’ Amtagvi study data shows 49 per cent response rate for commercialisation: San Carlos, California Thursday, July 17, 2025, 12:00 Hrs [IST] Iovance Biothe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback